Compare DSP Healthcare Fund vs SBI Healthcare Opportunities Fund
DSP Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.05
1.99
NAV
₹48.81
₹563.66
Fund Started
12 Nov 2018
04 Jun 1999
Fund Size
₹3750.04 Cr
₹5870.00 Cr
Exit Load
Exit load of 0.50% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
1 Year
11.11%
11.56%
3 Year
17.94%
20.58%
5 Year
13.22%
15.68%
Equity
92.16%
95.53%
Cash
7.84%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Ipca Laboratories Ltd. | 8.13% |
Sun Pharmaceutical Industries Ltd. | 7.44% |
Cipla Ltd. | 7.18% |
Sai Life Sciences Ltd. | 6.52% |
Gland Pharma Ltd. | 6.15% |
Apollo Hospitals Enterprise Ltd. | 6.07% |
Globus Medical Inc | 5.15% |
Alkem Laboratories Ltd. | 4.75% |
Divi's Laboratories Ltd. | 4.17% |
Cohance Lifesciences Ltd. | 3.79% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
12 Nov 2018
04 Jun 1999
